Our results suggest that down‐regulation of miR‐6076 could attenuate Aβ1‐42‐induced neuronal damage by targeting BCL6, which provided a possible target to pursue for prevention and treatment of Aβ‐induced neuronal damage in AD. The gene discussed is BCL6; the disease is Alzheimer disease.